292 related articles for article (PubMed ID: 37529485)
1. Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis.
Giriyappagoudar M; Vastrad B; Horakeri R; Vastrad C
Bioinform Biol Insights; 2023; 17():11779322231186719. PubMed ID: 37529485
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
3. Identifying
Ding J; Liu Y; Lai Y
PeerJ; 2020; 8():e10419. PubMed ID: 33282565
[TBL] [Abstract][Full Text] [Related]
4. Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis.
Ganekal P; Vastrad B; Vastrad C; Kotrashetti S
Ther Adv Cardiovasc Dis; 2023; 17():17539447231168471. PubMed ID: 37092838
[TBL] [Abstract][Full Text] [Related]
5. Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.
Giriyappagoudar M; Vastrad B; Horakeri R; Vastrad C
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137330
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes related to the progression of type 1 diabetes by computational analysis.
Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
BMC Endocr Disord; 2021 Apr; 21(1):61. PubMed ID: 33827531
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis.
Ghatnatti V; Vastrad B; Patil S; Vastrad C; Kotturshetti I
AIMS Neurosci; 2021; 8(2):254-283. PubMed ID: 33709028
[TBL] [Abstract][Full Text] [Related]
8. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses.
Long J; Zhang Z; Liu Z; Xu Y; Ge C
Oncol Lett; 2016 Feb; 11(2):1391-1397. PubMed ID: 26893748
[TBL] [Abstract][Full Text] [Related]
9. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis.
Tang Y; Zhang Z; Tang Y; Chen X; Zhou J
Oncol Lett; 2018 Aug; 16(2):2453-2461. PubMed ID: 30013637
[TBL] [Abstract][Full Text] [Related]
11. Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.
Kolur V; Vastrad B; Vastrad C; Kotturshetti S; Tengli A
BMC Cardiovasc Disord; 2021 Jul; 21(1):329. PubMed ID: 34218797
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
Tian X; Wang N
Oncol Lett; 2020 Apr; 19(4):3307-3315. PubMed ID: 32218868
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis.
Jin D; Jiao Y; Ji J; Jiang W; Ni W; Wu Y; Ni R; Lu C; Qu L; Ni H; Liu J; Xu W; Xiao M
PeerJ; 2020; 8():e9301. PubMed ID: 32587798
[TBL] [Abstract][Full Text] [Related]
14. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway.
Yao LC; Jiang XH; Yan SS; Wang W; Wu L; Zhai LL; Xiang F; Ji T; Ye L; Tang ZG
Oncol Lett; 2021 Apr; 21(4):326. PubMed ID: 33692858
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
[TBL] [Abstract][Full Text] [Related]
16. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
Sun Y; Cai D; Hu W; Fang T
Front Genet; 2022; 13():950136. PubMed ID: 36118873
[No Abstract] [Full Text] [Related]
17. Integrative analyses of potential biomarkers and pathways for non-obstructive azoospermia.
Zhong Y; Chen X; Zhao J; Deng H; Li X; Xie Z; Zhou B; Xian Z; Li X; Luo G; Li H
Front Genet; 2022; 13():988047. PubMed ID: 36506310
[No Abstract] [Full Text] [Related]
18. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression.
Pan Z; Li L; Fang Q; Zhang Y; Hu X; Qian Y; Huang P
Cancer Cell Int; 2018; 18():214. PubMed ID: 30598639
[TBL] [Abstract][Full Text] [Related]
19. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
Vastrad B; Vastrad C; Tengli A
Gene Rep; 2020 Dec; 21():100956. PubMed ID: 33553808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
